Biogen Inc. (BIIB)
NASDAQ · Healthcare
Biogen Inc. EBITDA 2007–2025
Biogen Inc. annual/quarterly ebitda history and growth rate from 2007 to 2022. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Biogen Inc. ebitda for the quarter ending March 31, 2022 was 753.8 M, a 29.98% decrease year-over-year.
- Biogen Inc. ebitda for the twelve months ending March 31, 2022 was 5.4 B, a 10.61% decrease year-over-year.
- Biogen Inc. annual ebitda for 2021 was 3.3 B, a 33.53% decrease from 2020.
- Biogen Inc. annual ebitda for 2020 was 5.0 B, a 33.30% decrease from 2019.
- Biogen Inc. annual ebitda for 2019 was 7.5 B, a 14.81% increase from 2018.
- Biogen Inc. annual ebitda for 2018 was 6.5 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biogen Inc. EBITDA — FAQ
Biogen Inc. (BIIB) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIIB's ebitda history?
The chart and table above show Biogen Inc.'s ebitda by year and by quarter, including the growth rate.